1-3 of 3
Carolina Viveiros
Close
Sort by
Journal Articles

Predicting Early Mortality in Multiple Myeloma Patients Treated with Novel Agents

Catarina Geraldes, MD PhD, Adriana Roque, MD, Ana Bela Sarmento-Ribeiro, MD PhD, Maria Leticia Ribeiro, MD PhD, Rui Bergantim, MD, Fernanda Trigo, MD, Sérgio Chacim, MD, Ana Macedo, Carolina Viveiros, Cristina Joao, MD PhD MSc, Manuel Neves, MD, Paulo Lucio
Journal: Blood
Blood (2018) 132 (Supplement 1): 5641.
https://doi.org/10.1182/blood-2018-99-117351
Published: 2018
Journal Articles

Serum Free Light Chain Ratio (FLCr) Is a Powerful Prognostic Factor For Survival In Newly Diagnosed Multiple Myeloma (MM) Eligible For High Dose Melphalan (HDM)

Graça Esteves, MD, Manuel L Neves, Helena Martins, Carlos M. Martins, MD, Maria Joao Costa, MD, Sara Valle, MD, Conceição Lopes, MD, João Raposo, MD, Lurdes Guerra, MD, Blanca Polo, MD, Ana Alho, Carolina Viveiros, MD, Susana Mendes, Rita Ferreira, Eduardo Espada, Inês Conde, Daniela Alves, Joao F Lacerda, MD, PhD, Helena Proença, MD, José A Carmo, MD
Journal: Blood
Blood (2013) 122 (21): 1873.
https://doi.org/10.1182/blood.V122.21.1873.1873
Published: 2013
Journal Articles

Serum Free Light Chain Ratio (FLCr) Is a Powerful Prognostic Factor For Survival In Newly Diagnosed Multiple Myeloma (MM) In The Era Of New Agents Namely On ISS Stage II Patients

Graça V Esteves, MD, Manuel L Neves, Helena F Martins, Maria Joao Costa, MD, Sara Valle, MD, João Raposo, MD, Carlos M. Martins, MD, Lurdes Guerra, MD, Conceição Lopes, MD, Susana Mendes, Ana Alho, Rita Ferreira, Carolina Viveiros, MD, Eduardo Espada, Inês Conde, Daniela Alves, Joao F Lacerda, MD, PhD, Blanca Polo, MD, Helena Proença, MD, José A Carmo, MD
Journal: Blood
Blood (2013) 122 (21): 3150.
https://doi.org/10.1182/blood.V122.21.3150.3150
Published: 2013